NBIX press release
RTPR•10/11/2026•16:01 ET
0
Key Highlights
- ➤Neurocrine executives to present at Jefferies Global Healthcare Conference November 17, 2026
- ➤Webcast scheduled for 3:30 p.m. Greenwich Mean Time
- ➤Replay available approximately one hour after the event for approximately one month
- ➤Portfolio includes FDA-approved treatments across neurological, psychiatric, endocrine and immunological disorders
Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference PR Newswire
SAN DIEGO, Nov. 10, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the 2026 Jefferies Global Healthcare Conference in London at 3:30 p.m. Greenwich Mean Time (10:30 a.m. Eastern Time) on November 17, 2026.
Get started
Create a free account to read the full story.